A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
- Funded by National Medical Research Council Singapore
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
National Medical Research Council SingaporePrincipal Investigator
A/Prof. David LyeResearch Location
SingaporeLead Research Institution
NCID (TTSH) SingaporeResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified